Part Number
Part Number:
NSN:
NIIN:
Item Name:
CIPROFLOXACIN CONCENTRATE FOR IN
Definition:
CAGE Information
| Code | Company |
|---|---|
| 3VBU6 | HOSPIRA INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN CONCENTRATE FOR INJ 400MG 40ML |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 40.000 MILLILITERS |
| AJCN | PROTECTIVE STORAGE FEATURE | REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| CQCT | PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| FEAT | SPECIAL FEATURES | 10MG CIPROFLOXACIN PER ML; 400MG/40 ML SINGLE DOSE VIAL; PRTOECT FROM LIGHT AND FROM FREEZING; USED ONLY TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; CONCENTRATE |